Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
04/2003
04/15/2003US6548298 Transcriptional unit complementary to human telomerase RNA sequence linked to regulating sequences
04/15/2003US6548291 Polynucleotide sequences/transgenic cells of Bacillus thuringiensis
04/15/2003US6548284 Membrane-bound metalloprotease and soluble secreted form thereof
04/15/2003US6548281 Polypeptides, polynucleotides formed via recombination; for screening for antibacterial compounds
04/15/2003US6548279 For polypeptides able to catalyze the enzymatic function of superoxide dismutase, carbonic anhydrase, or HIV protease
04/15/2003US6548268 A medium for isolating Staphylococcus aureus, comprises in a culture medium of Staphylococcus aureus atleast one of chromogenic agents:5-bromo-6-chloro-3-indoxylphosphate and 5-bromo-6-chloro-glucoside; and also contains deferoxamine
04/15/2003US6548266 The substrate for the phosphatase or protein kinase enzyme is immobilized on a solid support via covalent or non-covalent binding through a signal enhancing polymer
04/15/2003US6548263 Contacting hydroxyl groups on the substrage surface with a bifunctional molecule comprising a hydroxy-reactive group and a nucleophilic group to form a monolayer, applying stencil to the substrate to deposit cell repulsive or adhesive groups
04/15/2003US6548261 Transfection of neuronal cells with an expression vector comprising one or more oncogenes
04/15/2003US6548260 Separating blood sample serum or plasma, and exposing to acid and alkali solution treatment, contacting above sample with an antibody to PSA that binds PSA in PSA-alpha 2-macroglobulin complex, conjugating with solid phase
04/15/2003US6548259 Multiparametric fluorescence in situ hybridization
04/15/2003US6548257 Monitoring preferential expression; provide a pool of target ribonucleic acid sequences, hybridize to immobilized probes, measure nucleic acid hybridization to soild support
04/15/2003US6548255 Immobilization
04/15/2003US6548254 Methods and compositions for the manufacture of molecular beacons
04/15/2003US6548252 Electrochemically analyzing samples from selected areas of the body of a living organism for elevated free levels of nucleotide excision products resulting from DNA or RNA damage
04/15/2003US6548251 Inhibition of molecular and biological processes using modified oligonucleotides
04/15/2003US6548250 Methods for detection of a target nucleic acid sequence
04/15/2003US6548249 Fusions of scaffold proteins with random peptide libraries
04/15/2003US6548248 Placing the sterilization indicator (a DNA prepartion) in the sterilization chamber prior to beginning the sterilization cycle, after completing the cycle, withdrawing DNA, placing on a support and binding with dye, dipping into water
04/15/2003US6548247 Detection and mapping of point mutations using partial digestion
04/15/2003US6548246 Method and probes for the identification of microbial genes specifically induced during host infection
04/15/2003US6548245 Identifying a nucleic acid sequence exhibiting a polymorphism in an eotaxin gene, and the polymorphism comprises a substitution of adenine for gaunine 67 base pairs following the ATG initiation codon of the gene
04/15/2003US6548244 Process for typing HCV isolates
04/15/2003US6548021 Surface-bound, double-stranded DNA protein arrays
04/15/2003US6548018 To detect the presence of microbial contamination based on the luciferase/luciferin system; quick, easy to use, for use such as food preparation in fast food restaurants
04/15/2003US6547954 Reaction layer formed on the insulating substrate which contains an oxidoreductase and an electron acceptor, wherein the electron acceptor is ferricinium ion derived from ferrocene electrolyte.
04/15/2003CA2396662A1 Polymer sequence representation
04/15/2003CA2245594C Bioluminescent novelty items
04/15/2003CA2026280C Biotin-labelled dna by polymerase chain reaction and detection thereof
04/12/2003CA2403827A1 Compositions and methods for genetic analysis of polycystic kidney disease
04/10/2003WO2003030129A2 Labelled articles and uses thereof
04/10/2003WO2003029924A2 Adaptive baseline algorithm for quantitative pcr
04/10/2003WO2003029828A2 Screening method for different indications using bnpi and/or dnpi
04/10/2003WO2003029825A2 Method for predicting the sensitivity to chemotherapy
04/10/2003WO2003029823A1 Combinatorial protease substrate libraries
04/10/2003WO2003029821A1 Target assisted iterative screening (tais) : a novel screening format for large molecular repertoires
04/10/2003WO2003029819A1 Method of screening preventive/remedy for bone/joint diseases
04/10/2003WO2003029493A1 Diagnosis and treatment of vascular disease
04/10/2003WO2003029491A1 Enzymatic light amplification
04/10/2003WO2003029490A1 Methods and arrays for detecting biological molecules
04/10/2003WO2003029489A1 Methods for detection of target molecules and molecular interactions
04/10/2003WO2003029486A2 Single nucleotide polymorphisms predicting cardiovascular disease
04/10/2003WO2003029485A2 Specific differential display arrays
04/10/2003WO2003029484A2 Antimicrobial methods and materials
04/10/2003WO2003029483A1 A method for testing the effect of nutrients on colonisation resistance of humans
04/10/2003WO2003029482A2 Diagnosing, treating, and preventing cancer using cables
04/10/2003WO2003029481A2 Detection of dna hybridization on surfaces
04/10/2003WO2003029480A2 Measurements of multiple molecules using a cryoarray
04/10/2003WO2003029479A2 Sensitive and rapid detection of pathogenic organisms and toxins using fluorescent polymeric lipids
04/10/2003WO2003029468A1 Compositions and methods for the therapy and diagnosis of ovarian cancer
04/10/2003WO2003029464A2 Genes associated with mast cell activation
04/10/2003WO2003029461A1 A method of genetic screening using an amplifiable gene
04/10/2003WO2003029459A2 Micro-rna molecules
04/10/2003WO2003029456A1 Multi-chain eukaryotic display vectors and uses thereof
04/10/2003WO2003029451A2 Histone deacetylase 9
04/10/2003WO2003029450A1 Nucleic acid sequences encoding lysk from different borrelia strains and uses thereof
04/10/2003WO2003029441A1 Method of amplifying dna chip signals
04/10/2003WO2003029438A2 Identifying agents that prevent palindrome formation and gene amplification
04/10/2003WO2003029437A2 Secreted proteins
04/10/2003WO2003029435A2 Detection of polynucleotide hybridization
04/10/2003WO2003029428A2 Use of calmodulin kinase ii inhibitors to treat myocardial dysfunction in structural heart disease
04/10/2003WO2003029424A2 Novel proteins and nucleic acids encoding same
04/10/2003WO2003029423A2 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
04/10/2003WO2003029422A2 Noonan syndrome gene
04/10/2003WO2003029421A2 Regulated breast cancer genes
04/10/2003WO2003029419A2 Three dimensional structure of crystalline grp94 binding domain, and its methods of use
04/10/2003WO2003029418A2 Proliferation and differentiation of stem cells using extracellular matrix and other molecules
04/10/2003WO2003029413A2 A novel g protein-coupled receptor, gave 10
04/10/2003WO2003029410A2 METHODS OF USING 69039, A NOVEL HUMAN Na/Ca EXCHANGER FAMILY MEMBER
04/10/2003WO2003029409A2 Methods for generating, selecting, and identifying compounds which bind a target molecule
04/10/2003WO2003029407A2 Isolated nucleic acid molecules encoding a bacterial uracil transport protein and a bacterial uracil phosphoribosyl-transferase enzyme, cells transformed therewith and uses thereof
04/10/2003WO2003029405A2 Methods and materials relating to stem cell growth factor-like polypeptides and polynucleotides
04/10/2003WO2003029402A2 Unique properties of stem cells
04/10/2003WO2003029293A2 Modulators of notch ic protease activity for use in immunotherapy
04/10/2003WO2003029292A2 Gene regulatory peptides
04/10/2003WO2003029287A1 Ferroportin-1 mutant
04/10/2003WO2003029277A2 Modulators of lymphocyte activation and migration
04/10/2003WO2003029273A2 Classification of lung carcinomas using gene expression analysis
04/10/2003WO2003028737A1 Anti-viral agents and in-vitro method for the identification of candidates able to inhibit binding of polymerase to epsilon
04/10/2003WO2003028663A2 Prolyl-4-hydroxylases
04/10/2003WO2003028647A2 Identification of genes involved in restenosis and in atherosclerosis
04/10/2003WO2003028631A2 Drug targets for alzheimer's disease and other diseases associated with decreased neuronal metabolism
04/10/2003WO2003028627A2 Method for detecting procoagulant conditions
04/10/2003WO2003028543A2 Nucleic acid molecules, polypeptides and uses therefor, including diagnosis and treatment of alzheimer's disease
04/10/2003WO2003028539A2 Materials and methods for the diagnosis of pediatric tumors
04/10/2003WO2003028537A2 Methods for diagnosing and treating diseases and conditions of the heart or digestive system, and cancer
04/10/2003WO2003028536A2 Methods for diagnosing and treating heart disease
04/10/2003WO2003028531A2 Detection of tumor rna in plasma and serum
04/10/2003WO2003028457A1 Method of restoring ciliated cell motility
04/10/2003WO2003020979A8 Methods for preparing nucleic acid samples
04/10/2003WO2003015711A9 Combination motif immune stimulatory oligonucleotides with improved activity
04/10/2003WO2003008575A3 Dna sequences for regulating transcription
04/10/2003WO2003008572A8 Methods of creating genetic diversity
04/10/2003WO2003008538A3 Gene expression profiling
04/10/2003WO2003007971A9 Improved heteropolymer complexes and methods for their use
04/10/2003WO2003005812A3 Modulation of metabolism of steroids and xenobiotics
04/10/2003WO2003004693A3 Methods and compositions for modulating adenosine triphosphate (atp) in cells and preventing cell injury or death via post-translational modifications to atp synthase
04/10/2003WO2003000861A9 Eukaryotic genes involved in adult lifespan regulation
04/10/2003WO2002102980A3 Kits and methods for assessing leptin-mediated lipid matabolism
04/10/2003WO2002102768A3 Regulation of neuronal function through metabotropic glutamate receptor signaling pathways